We are live on ! Find out more
GCVRZ

Sanofi Contingent Value Rights
GCVRZ

Delisted

GCVRZ was delisted on the 3rd of March, 2020.

Back to rankings

106 hedge funds and large institutions have $76.1M invested in Sanofi Contingent Value Rights in 2018 Q2 according to their latest regulatory filings, with 15 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 8 closing their positions.

New
Increased
Maintained
Reduced
Closed

88% more first-time investments, than exits

New positions opened: 15 | Existing positions closed: 8

19% more capital invested

Capital invested by funds: $64M → $76.1M (+$12.1M)

6% more funds holding

Funds holding: 100 → 106 (+6)

0% more funds holding in top 10

Funds holding in top 10: 1 → 1 (0)

31% less repeat investments, than reductions

Existing positions increased: 11 | Existing positions reduced: 16

Holders
106
Holders Change
+6
Holders Change %
+6%
% of All Funds
2.43%
Holding in Top 10
1
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.02%
New
15
Increased
11
Reduced
16
Closed
8
Calls
$724K
Puts
–
Net Calls
+$724K
Net Calls Change
+$112K

Top Buyers

Rank Fund Capital Flow
1
HCM
Highbridge Capital Management
New York
+$304K
2
SAM
Silverback Asset Management
North Carolina
+$157K
3
BRF
B. Riley Financial
California
+$114K
4
CI
Cowen Inc
New York
+$17.7K
5
Susquehanna International Group
Susquehanna International Group
Pennsylvania
+$13.5K

Top Sellers

Rank Fund Capital Flow
1
CL
CSS LLC
Illinois
-$71.2K
2
PC
Pomelo Capital
New York
-$66.8K
3
PC
Permanens Capital
New York
-$48K
4
TL
TowerView LLC
New York
-$46.6K
5
DBG
De Burlo Group
Massachusetts
-$16K
Name Holding Trade Value Shares
Change 		Change in
Stake
LPL Financial
51
LPL Financial
California
$6K +$5.24K +11,243 New
ISL
52
Ingalls & Snyder LLC
New York
$5K -$2.33K -5,000 -33%
DA
53
Dillon & Associates
Michigan
$5K – – –
RJA
54
Raymond James & Associates
Florida
$5K +$7 +16 +0.1%
Citadel Advisors
55
Citadel Advisors
Florida
$5K +$4.78K +10,264 New
Deutsche Bank
56
Deutsche Bank
Germany
$4K – – –
PNC Financial Services Group
57
PNC Financial Services Group
Pennsylvania
$4K – – –
AG
58
Advisor Group
Arizona
$3K -$10 -21 -0.4%
Bank of Montreal
59
Bank of Montreal
Ontario, Canada
$3K – – –
BNP Paribas Financial Markets
60
BNP Paribas Financial Markets
France
$2.73K – – –
Royal Bank of Canada
61
Royal Bank of Canada
Ontario, Canada
$2K +$236 +506 +11%
CIBC Private Wealth Group
62
CIBC Private Wealth Group
Georgia
$1K – – –
LTFS
63
Ladenburg Thalmann Financial Services
Florida
$1K – – –
SIM
64
Sonora Investment Management
Arizona
$1K – – –
WTC
65
WhitTier Trust Company
Nevada
$1K – – –
US Bancorp
66
US Bancorp
Minnesota
$1K +$174 +373 +29%
ACA
67
Atlas Capital Advisors
Wyoming
$138 – – –
RE
68
RBC Europe
United Kingdom
$65 – – –
BCWM
69
Bartlett & Co Wealth Management
Ohio
$50 +$47 +100 New
CI
70
Cowen Inc
New York
$19 +$17.7K +37,900 New
ECM
71
Estabrook Capital Management
New York
$7 – – –
PC
72
Permanens Capital
New York
– -$48K -112,982 Closed
DBG
73
De Burlo Group
Massachusetts
– -$16K -39,800 Closed
CTC
74
Central Trust Company
Missouri
– -$193 -414 -21%
SWA
75
Sutton Wealth Advisors
Florida
– -$142 -336 Closed
1 2
3
4

GCVRZ Hedge Fund Activity: Q2 2018 in Review

106 of the 4,368 institutional investors tracked by Wall St. Rank reported a position in Sanofi Contingent Value Rights (GCVRZ) for Q2 2018, worth a combined $76.1M — up 19% from $64M a quarter earlier.

Buyers outnumbered sellers: 15 funds opened new GCVRZ positions and 8 closed out — a net gain of 7 holders — while 11 added to existing stakes and 16 trimmed.

The largest buyer was Highbridge Capital Management, adding an estimated $304K. The largest seller was CSS LLC, cutting an estimated $71.2K.

  • 106 institutional investors held Sanofi Contingent Value Rights (GCVRZ) as of Q2 2018, up from 100 in Q1 2018.
  • Funds reported $76.1M of Sanofi Contingent Value Rights stock for Q2 2018, up 19% quarter-over-quarter.
  • 15 funds opened new Sanofi Contingent Value Rights positions in Q2 2018 and 8 closed out, a net change of +7 holders.
  • The largest Sanofi Contingent Value Rights buyer in Q2 2018 was Highbridge Capital Management, an estimated $304K added.
  • The largest Sanofi Contingent Value Rights seller in Q2 2018 was CSS LLC, an estimated $71.2K sold.

Based on aggregated 13F filings for Q2 2018.